 Neurocrine Biosciences, Inc. NASDAQ:NBIX Q3 2022 Earnings Conference Call November 1, 2022 8:00 AM ET Company Participants Todd Tushla - VP of IR Kevin Gorman - CEO Matt Abernethy - CFO Eric Benevich - Chief Commercial Officer Eiry Roberts - Chief Medical Officer Kyle Gano - Chief Business Development Strategy Officer Conference Call Participants Tazeen Ahmad - Bank of America Paul Matteis - Stifel Phil Nadeau - Cowen Company Neena Bitritto-Garg - Citi Anupam Rama - JPMorgan Brian Abrahams - RBC Capital Markets Carter Gould - Barclays Chris Shibutani - Goldman Sachs Myles Minter - William Blair Brian Skorney - Baird Laura Chico - Wedbush Ashish Sharma - UBS Jeff Hung - Morgan Stanley Jay Olson - Oppenheimer Marc Goodman - SVB David Amsellem - Piper Sandler Uy Ear - Mizuho Securities Conor MacKay - BMO Capital Markets Yatin Suneja - Guggenheim Partners Mohit Bansal - Wells Fargo Sumant Kulkarni - Canaccord Genuity Operator Good day, everyone. And welcome to todays Neurocrine Biosciences Reports Third Quarter Results. 